Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Medu Norge AS
AS
Active
Org 958103425
Snarøyveien 36, 1364
Fornebu
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1990 · 36 years old
29 employees
www.endotech.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Medu Norge AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
166M
124M
83M
41M
0M
2021: 65M
65M
2021
2022: 62M (-5% vs 2021)
62M
-5%
2022
2023: 68M (+10% vs 2022)
68M
+10%
2023
2024: 79M (+16% vs 2023)
79M
+16%
2024
2025: 133M (+68% vs 2024)
133M
+68%
2025
EBITDA
NOK millions
27M
21M
14M
7M
0M
2021: 8M
8M
2021
2022: 2M (-75% vs 2021)
2M
-75%
2022
2023: 4M (+100% vs 2022)
4M
+100%
2023
2024: 7M (+75% vs 2023)
7M
+75%
2024
2025: 22M (+214% vs 2024)
22M
+214%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
133 010
79 470
67 946
62 413
65 332
Staff expenses
−19 718
−15 523
−14 345
−13 476
−12 646
EBITDA
21 666
7 407
4 227
2 077
7 634
Depreciation & amort.
−1 243
−134
−424
−158
−184
EBIT
20 424
7 274
3 803
1 918
7 450
Net financials
−1 185
−1 538
−874
−133
−331
Profit before tax
19 239
5 735
2 929
1 785
7 119
Tax
4 384
1 320
641
487
1 602
Net profit
14 855
4 415
2 288
1 298
5 517
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
63 020
46 344
29 594
23 992
28 347
Equity
21 588
7 030
1 295
9 693
8 314
Long-term debt
0
16 390
1 438
1 000
325
Short-term debt
41 228
22 924
26 861
13 298
19 708
Total debt
41 433
39 314
28 299
14 298
20 033
Financial ratios
5-year trend
EBITDA margin
16,3 %
This company
15,8 %
Market median
This company
Market median
3% above market
2021
2025
Equity ratio
34,3 %
This company
38,2 %
Market median
This company
Market median
10% below market
2021
2025
Return on equity
68,8 %
This company
18,4 %
Market median
This company
Market median
274% above market
2021
2025
Net profit margin
11,2 %
This company
8,1 %
Market median
This company
Market median
38% above market
2021
2025
Asset turnover
2,11×
This company
1,12×
Market median
This company
Market median
88% above market
2021
2025
Debt / equity
1,92×
This company
0,62×
Market median
This company
Market median
210% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Medu Norge AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
